Have you seen the latest content on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: CFF Programs Strive to Reduce Patients’ Isolation Proteostasis’ Triple Combo Improves Lung Function in CF Patients, Phase 2 Trial Shows CFF Programs Strive to Reduce Patients’ Isolation Dec 20, 2019 07:00 am | Larry Luxner Oregon retiree Carol Birch, 59, considers herself especially lucky to have made it this far in life. “I’ve never felt that I fit the typical role of someone with cystic fibrosis (CF),” Birch told attendees at the 2019 North American Cystic Fibrosis Conference (NACFC) in Nashville, Tennessee. Diagnosed at the age of 15, Birch said she […] The post CFF Programs Strive to Reduce Patients’ Isolation appeared first on Cystic Fibrosis News Today. Read More Proteostasis’ Triple Combo Improves Lung Function in CF Patients, Phase 2 Trial Shows Dec 19, 2019 07:00 am | Joana Carvalho, MSc A triple combination of dirocaftor (PTI-808), Proteostasis Therapeutics’ investigational CFTR potentiator, with a proprietary CFTR amplifier and corrector led to significant improvements in lung function in patients with cystic fibrosis (CF) carrying the F508del mutation, according to topline data from a Phase 2 trial. CF is a genetic disorder caused by mutations in the CFTR […] The post Proteostasis’ Triple Combo Improves Lung Function in CF Patients, Phase 2 Trial Shows appeared first on Cystic Fibrosis News Today. Read More Recent News Vertex and Republic of Ireland Reach Agreement on Reimbursement for Triple Combination Therapy Here’s How I’m Failing to Support the Mental Health Community CF Newborn Screening Improves Weight and Lung Outcomes, but Has No Impact on Social Inequalities, Study Suggests Diet to Help Manage Glucose in CF Patients: A Nutritionist’s View My CF Is My Burden Alone